Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
Thrombosis Research (2020) - Comments
pubmed: 32977137  doi: 10.1016/j.thromres.2020.09.026  issn: 0049-3848  issn: 1879-2472 

Anna Cristina Bertoldi Lemos, Douglas Alexandre Do Espírito Santo, Maísa Cabetti Salvetti, Renato Noffs Gilio, Lucas Barbosa Agra, Antonio Pazin-Filho, Carlos Henrique Miranda